Sunho Biologics Provides Transaction Update

Sunho Biologics,Inc. (HK:2898) has released an update.

Sunho Biologics, Inc. has issued a supplemental announcement to their previous disclosures regarding a transaction related to fund subscriptions, providing the Chinese names of the general partners involved from Prudent Wealth, Vanguard, and North Rock. The company emphasizes that all other details previously announced remain valid, and this update should be read in conjunction with those announcements for complete understanding.

For further insights into HK:2898 stock, check out TipRanks’ Stock Analysis page.